evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract
15573,GENE_BACKGROUND,,"The GNAQ (guanine nucleotide binding protein q polypeptide) gene encodes for members of the q class of G-protein alpha subunit, one of three subunits that comprise the heterotrimeric guanine nucleotide-binding proteins (G-proteins). These G-proteins participate in signal transduction between G-protein coupled receptors (GPCRs) and downstream effector pathways including the MAPK pathway. Mutations in GNAQ cause activation of the MAPK pathway through the upregulation of protein kinase C (PMID:19078957). Mutations in codon 209 (within the RAS-like domain) transform GNAQ into a dominant-acting oncogene that contributes to the development of a subset of melanocytic neoplasms that do not harbor the more common melanoma-associated somatic mutations in BRAF and NRAS (PMID:19078957). Approximately 85% of uveal melanomas harbor mutually exclusive mutations of either GNA11 or GNAQ (PMID: 24713608). Identification of GNAQ codon 209 mutations may also be helpful in differentiating leptomeningeal melanocytic lesions from melanotic schwannoma (PMID: 20865267). GNAQ mutations in other types of human neoplasms appear to be quite rare (PMID: 23640210).",,2017-02-21,,2776,GNAQ,G protein subunit alpha q,True,ENST00000286548,NM_002072.3,G-ALPHA-q,GAQ,SWS,False,19078957,Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi.,Nature,2018-01-29T20:09:00,457,7229,599-602,Van Raamsdonk CD et al,doi: 10.1038/nature07586,,2018-01-29T06:02:00,,23640210,The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer.,Nature reviews. Cancer,2018-06-01T20:13:00,13,6,412-24,O'Hayre M et al,doi: 10.1038/nrc3521,,0001-06-01,,20865267,Improved discrimination of melanotic schwannoma from melanocytic lesions by combined morphological and GNAQ mutational analysis.,Acta neuropathologica,2017-12-01T20:10:00,120,6,755-64,KÃ¼sters-Vandevelde HV et al,doi: 10.1007/s00401-010-0749-z,,0001-12-01,,24713608,Recent developments in prognostic and predictive testing in uveal melanoma.,Current opinion in ophthalmology,2018-05-01T20:14:00,25,3,234-9,Field MG et al,doi: 10.1097/ICU.0000000000000051,,0001-05-01,
15572,GENE_SUMMARY,,"GNAQ, an intracellular signaling protein, is recurrently mutated in uveal melanoma.",,2017-02-21,,2776,GNAQ,G protein subunit alpha q,True,ENST00000286548,NM_002072.3,G-ALPHA-q,GAQ,SWS,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
